Synergy Biomedical, founded in 2011, is a privately-held medical device company in the United States. It operates within the Biotechnology, Health Care, and Medical Devices industries, focusing on innovative bone graft technology through its flagship product, BioSphere® particles.
The company is revolutionizing bone healing with its advanced bioactive glass solutions. By utilizing its proprietary BIOSPHERE Technology, Synergy Biomedical aims to enhance patient outcomes in the orthopedic and spinal surgery markets. Its approach centers on optimizing bioactive glass particles, which have demonstrated efficacy in improving bone healing.
Since its inception, Synergy Biomedical has attracted attention with a $611.90K Seed Round investment recorded in March 2014, although no specific investors were disclosed. The company actively seeks independent sales distributors with expertise in orthopedic and spinal surgery to expand its market reach.